Mobile UPI  |   About UPI  |   UPI en Español  |   UPI Arabic  |   UPIU  |   My Account
Search:
Go

Topic: Janet Woodcock

Latest Headlines

FDA's Woodcock discusses pain management
WASHINGTON, Nov. 30 (UPI) -- The U.S. Food and Drug Administration says it is trying to strike a balance between access to pain medications and the associated risks posed by analgesics.
WASHINGTON, Aug. 12 (UPI) -- A California complaint has led to a conflict-of-interest investigation involving the head of U.S. drug approvals, the Food and Drug Administration confirms.
WASHINGTON, June 12 (UPI) -- The U.S. Food and Drug Administration and the European Medicines Association say they plan to work together in assessing the safety of new drugs.
WASHINGTON, May 30 (UPI) -- The U.S. Food and Drug Administration issued a public health advisory that chlorofluorocarbon, or CFC-propelled inhalers will not be available next year.
WASHINGTON, May 2 (UPI) -- A top U.S. Food and Drug Administration official reportedly has refused to support Democrats on tougher inspection plans.
WASHINGTON, April 29 (UPI) -- The U.S. Federal Drug Administration said Tuesday it suspects contamination of the blood thinner heparin that led to 81 deaths was deliberate.
WASHINGTON, April 22 (UPI) -- U.S. regulators said contaminated blood thinner from China, linked to 81 deaths in the United States, has been found in several countries.
INDIANAPOLIS, April 16 (UPI) -- A major U.S. health insurer says it is developing a program to monitor the safety of drugs after they have been approved for market.
WASHINGTON, March 20 (UPI) -- The U.S. Food and Drug Administration says the contaminant found in Baxter International's heparin blood thinner is oversulfated chondroitin sulfate.
WASHINGTON, March 11 (UPI) -- The U.S. Food and Drug Administration has selected Dr. Janet Woodcock to become the agency's director of drug evaluation and research.
view more

Quotes

view more
1 of 20
Syrians Protest Against the President Bashar al-Assad
View Caption